Applied Therapeutics, Inc. Announces Positive Results from 1

Applied Therapeutics, Inc. announced positive interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary endpoints and several key secondary endpoints were achieved. The...

Related Keywords

, Health Index , Therapeutics Inc , Applied Therapeutics , Sorbitol Dehydrogenase , Aldose Reductase Inhibitor , New Drug Application , Analysis Results , Markets ,